Recruiting Valvular Heart Disease Studies in Minneapolis
About Valvular Heart Disease Clinical Trials in Minneapolis
Valvular heart disease occurs when one or more heart valves do not function properly, disrupting blood flow through the heart. Common types include aortic stenosis and mitral regurgitation. Treatment ranges from monitoring to surgical valve repair or replacement.
There are currently 7 valvular heart disease clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 4,480 participants. Research is being sponsored by Anteris Technologies Ltd., Abbott Medical Devices, Universitätsklinikum Hamburg-Eppendorf and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Valvular Heart Disease Clinical Trials in Minneapolis — FAQ
Are there valvular heart disease clinical trials in Minneapolis?
Yes, there are 7 valvular heart disease clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Minneapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.
Are clinical trials in Minneapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.
What valvular heart disease treatments are being tested?
The 7 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for valvular heart disease.
Data updated July 13, 2026 from ClinicalTrials.gov